InvestorLens

2824100 — ABBOTT LABS

Public company

Sign in to save2 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying 2824100?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
95
Institutional Conviction
Strong distribution · 0 buying vs 2 selling last quarter
4
Macro Tailwind
Macro conditions are mixed for this sector
52
Why? — Evidence & Confidence ▾

Of 2 tracked investors who changed their 2824100 position last quarter, 0 bought and 2 sold (0% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 52/100 in a Squeeze regime).

Supporting evidence
  • +2 tracked investors reported holding 2824100 at their latest filing
Contradicting evidence — always shown
  • −2 tracked investors reduced or exited last quarter (0 reduced, 2 sold out)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/4/2026.

About ABBOTT LABS (2824100)

ABBOTT LABS (2824100) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $649,933. Across recent filings, tracked investors recorded 3 new positions, 1 increased, 0 reduced, and 2 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in 2824100

67
/100
Institutional Accumulation
Added / Increased4
Reduced0
Exited2
BearishBullish
Crowded Trade Score™

How many top investors track 2824100

13
/100
Undiscovered
2investors

Only 2 tracked investors report this position.

UndiscoveredCrowded
151015+

2824100 Ownership Composition

How ABBOTT LABS is held across tracked investor types, based on reported 13F positions.

Dominant Type
Other
100% of tracked value
Institutions
2
tracked investors
Total Reported
$665.3K
combined 13F value
Sectors1
  • Other100.0%
Other(2)
100.0%

Tracked investors reporting 2824100

  • Ken GriffinDec 31, 2025
    Citadel Advisors
    Shares
    5.2M
    Value
    $649.9K
    % Portfolio
    0.00%
  • Ray DalioDec 31, 2025
    Bridgewater Associates
    Shares
    122.7K
    Value
    $15.4K
    % Portfolio
    0.00%

Recent activity

Frequently asked questions

How many institutional investors hold 2824100?
2 tracked institutional investors disclosed a position in 2824100 (ABBOTT LABS) in their most recent 13F filing.
Who is the largest institutional holder of 2824100?
Ken Griffin, Citadel Advisors, holds the largest disclosed position in 2824100, valued at $649,933.
Did institutional ownership of 2824100 increase or decrease?
Across recent 13F filings, tracked investors recorded 3 new positions, 1 increased, 0 reduced, and 2 fully exited 2824100.
Where does this 2824100 ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.